Literature DB >> 1546784

Legal needle buying in St. Louis.

W M Compton1, L B Cottler, S H Decker, D Mager, R Stringfellow.   

Abstract

This study sought to determine if and why barriers to the over-the-counter purchase of syringes in the St. Louis metropolitan area might exist, given that no ordinance prohibits such a sale there. Two male research assistants (one African American, one White) approached 33 of the area's pharmacies to buy syringes. In 14 of those pharmacies, either the purchase was refused or the minimum number of syringes that could be bought was so large (at least 100) that the sale was not practical. Racial bias in rates of refusal and implications for prohibiting or restricting legal availability of syringes are discussed.

Mesh:

Year:  1992        PMID: 1546784      PMCID: PMC1694100          DOI: 10.2105/ajph.82.4.595

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  6 in total

1.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

Authors:  J R Robertson; A B Bucknall; P D Welsby; J J Roberts; J M Inglis; J F Peutherer; R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

Review 2.  AIDS in New York City: the role of intravenous drug users.

Authors:  A Ron; D E Rogers
Journal:  Bull N Y Acad Med       Date:  1989-09

3.  US cities struggle to implement needle exchanges despite apparent success in European cities.

Authors:  C A Raymond
Journal:  JAMA       Date:  1988-11-11       Impact factor: 56.272

4.  The effects of the liberalization of syringe sales on the behaviour of intravenous drug users in France.

Authors:  F R Ingold; S Ingold
Journal:  Bull Narc       Date:  1989

5.  Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users.

Authors:  R T D'Aquila; L R Peterson; A B Williams; A E Williams
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

Review 6.  Prevalence of HIV infection among intravenous drug users in the United States.

Authors:  R A Hahn; I M Onorato; T S Jones; J Dougherty
Journal:  JAMA       Date:  1989-05-12       Impact factor: 56.272

  6 in total
  11 in total

1.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

2.  Report card on our national response to the AIDS epidemic--some A's, too many D's.

Authors:  D E Rogers
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

3.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

4.  Prevention of sexually transmitted HIV infection: A meta-analytic review of teh behavioral outcome literature.

Authors:  S C Kalichman; M P Carey; B T Johnson
Journal:  Ann Behav Med       Date:  1996-03

5.  Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Authors:  Hannah L F Cooper; Brian H Bossak; Barbara Tempalski; Samuel R Friedman; Don C Des Jarlais
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

6.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

7.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

8.  Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now?

Authors:  Richard S Garfein; Thomas J Stopka; Patricia B Pavlinac; Alessandra Ross; B Karen Haye; Elise D Riley; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

9.  Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.

Authors:  Saira S Siddiqui; Richard F Armenta; Jennifer L Evans; Michelle Yu; Jazmine Cuevas-Mota; Kimberly Page; Peter Davidson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2015-06-24

10.  Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.

Authors:  Elizabeth C Costenbader; William A Zule; Curtis C Coomes
Journal:  Int J Drug Policy       Date:  2010-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.